You want the most extensive long-term safety data currently available
GLP-1 is responsible for stimulating insulin release from the pancreas, reducing glucagon secretion (a hormone that increases blood sugar levels), slowing down stomach emptying, and promoting a feeling of fullness after meals
All of this stuff just scares the crap out of me, Randy Seeley, a University of Michigan medical professor and GLP-1 agonist expert, told The Atlantic in reference to the unknown side effects of gray market drugs
Genes 15 (9), 1234
Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
A thoughtfully chosen snack offers another opportunity to add nutrients that support energy, fullness, and overall health